Author: Rui Xiong; Leike Zhang; Shiliang Li; Yuan Sun; Minyi Ding; Yong Wang; Yongliang Zhao; Yan Wu; Weijuan Shang; Xiaming Jiang; Jiwei Shan; Zihao Shen; Yi Tong; Liuxin Xu; Chen Yu; Yingle Liu; Gang Zou; Dimitri Lavillete; Zhenjiang Zhao; Rui Wang; Lili Zhu; Gengfu Xiao; Ke Lan; Honglin Li; Ke Xu
Title: Novel and potent inhibitors targeting DHODH, a rate-limiting enzyme in de novo pyrimidine biosynthesis, are broad-spectrum antiviral against RNA viruses including newly emerged coronavirus SARS-CoV-2 Document date: 2020_3_12
ID: hq5um68k_20
Snippet: The data in all refresh DHODH as an attractive host target in treating viral disease with equivalent efficacy to DAA drug, and is advantageous when facing DAA-drugresistant viruses......
Document: The data in all refresh DHODH as an attractive host target in treating viral disease with equivalent efficacy to DAA drug, and is advantageous when facing DAA-drugresistant viruses.
Search related documents:
Co phrase search for related documents- daa drug and viral disease: 1
- equivalent efficacy and viral disease: 1
- host target and viral disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- host target and viral disease treat: 1
Co phrase search for related documents, hyperlinks ordered by date